Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Attività fisica virtuale Esercizio da seduti - Fase 2 (V-PASE)

18 settembre 2026 aggiornato da: Janice Eng, University of British Columbia

Assessing a Telehealth Seated Exercise Program on Post-stroke Balance and Mobility: A Mixed-method Design

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.

Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Panoramica dello studio

Stato

Attivo, non reclutante

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor.

Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.

Tipo di studio

Interventistico

Iscrizione (Stimato)

100

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 2G9
        • GF Strong Rehabilitation Centre
    • Manitoba
      • Winnipeg, Manitoba, Canada
        • University of Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Canada
        • Nova Scotia Health
    • Ontario
      • London, Ontario, Canada
        • Western University
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada
        • University of Saskatchewan

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

Participants must meet the following inclusion criteria:

  • Adult (as defined by Province)
  • Chronic stroke (more than 6 months post-stroke)
  • Ability to stand up from a chair
  • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
  • Able to safely engage in exercise and tolerate 60 minutes of exercises
  • Able to communicate in English
  • Have access to a tablet, computer, or laptop with internet and email access

Exclusion Criteria:

Participants will be excluded if they meet any of the following criteria:

  • Participating in formal exercise or rehabilitation activities
  • Participating in > 30 minutes/day of physical activity (moderate intensity)
  • Participating in another study that may affect outcomes to this study
  • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
  • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
  • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: 10-week group

Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration.

The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

Nessun intervento: Delayed 2-week group (Boot Camp)

The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
30 Second Sit-to-Stand
Lasso di tempo: Immediately post-intervention (following 10-week trial)

Assessment of balance and lower extremity strength.

Immediately post-intervention (following 10-week trial)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Timed Up and Go
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

Participants stand up from a chair, walk 3 metres, turn around and then sit back down. The TUG assesses balance, mobility and turning ability

Immediately post-intervention, and retention (2-months post-intervention)
Tandem Stance
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

Measures balance in standing as reported in the Short Physical Performance Battery Protocol

Immediately post-intervention, and retention (2-months post-intervention)
Modified Telehealth Fugl-Meyer
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

The modified virtual Fugl-Meyer assess lower extremity impairments in those with stroke

Immediately post-intervention, and retention (2-months post-intervention)
Stroke Impact Scale
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

A self-reported measure of stroke-related disability. There are 8 domains with each item rated using a 5-point Likert scale, where lower scores mean greater difficulty to complete the item.

Immediately post-intervention, and retention (2-months post-intervention)
Activities-Specific Balance Confidence (ABC)
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

The ABC scale is a 16-item questionnaire where a participant rates their confidence in performing activities from 0% to 100% (higher percentages indicate greater self-efficacy).

Immediately post-intervention, and retention (2-months post-intervention)
Fatigue Severity Scale
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

Questionnaire assessing the impact of fatigue on daily tasks and activities. There are 9 questions, each scored from 1 to 7 (1 = strongly disagree; 7 = strong agreement).

Immediately post-intervention, and retention (2-months post-intervention)
Quality of Life (EQ-5D-5L)
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

The EQ-5D-5L assess self-care, mobility, depression/anxiety, pain, and usual activities. Each is scored with 5 levels (1=no problems, 5=major problems). Overall health on the day is scored from 0% (worst health) to 100% (best health).

Immediately post-intervention, and retention (2-months post-intervention)
Patient Health Questionnaire-4 (PHQ-4)
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

The PHQ-4 focuses on depression and anxiety. Questions are scored from 0 to 3 (0=not at all; 3 = Nearly every day).

Immediately post-intervention, and retention (2-months post-intervention)
Montreal Cognitive Assessment scale (MoCA-BLIND)
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

The MoCA-BLIND assess six different cognitive domains (excludes visual stimulus) over the phone: memory, attention, language, abstraction, delayed recall, and orientation. The MoCA-BLIND is scored from 0-22 (22 = no cognitive impairments).

Immediately post-intervention, and retention (2-months post-intervention)
Lipid Profiles
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Fasting Glucose
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Glucose (HbA1c)
Lasso di tempo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
30 Second Sit-to-Stand
Lasso di tempo: Retention (2-months post-intervention)

Assessment of balance and lower extremity strength.

Retention (2-months post-intervention)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Feasibility Indicator: Compliance
Lasso di tempo: Through study completion (approximately 10 weeks)

Percentage of participants that attend exercise sessions.

Through study completion (approximately 10 weeks)
Feasibility Indicator: Safety
Lasso di tempo: Through study completion (approximately 10 weeks)

Number of adverse events that occur during assessments or exercise sessions.

Through study completion (approximately 10 weeks)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

11 ottobre 2023

Completamento primario (Stimato)

31 dicembre 2026

Completamento dello studio (Stimato)

31 marzo 2027

Date di iscrizione allo studio

Primo inviato

17 gennaio 2023

Primo inviato che soddisfa i criteri di controllo qualità

1 febbraio 2023

Primo Inserito (Effettivo)

13 febbraio 2023

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

23 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • H22-02549

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .